Our values and aspirations describe who we are and where we want to go. Our Pharmacosmos Code of Conduct reflects these and provides clear guidance and standards to follow to ensure that we maintain required standards, do not compromise on quality or business ethic matters and act and make decisions in an ethically acceptable manner, even when confronted with difficult situations.
Click on the fullscreen icon and read the PDF on your screen.
Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.
Pharmacosmos has subsidiaries in US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
